Quantum BioPharma Ltd. f/k/a FSD Pharma, Inc.
Case Overview
40 Days Left to Seek Lead Plaintiff
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 02/17/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: Quantum BioPharma Ltd. f/k/a FSD Pharma, Inc. |
| Court: | Court: Southern District of New York |
| Case Number: | Case Number: 1:25cv10565 |
| Class Period: | Class Period: 01/06/2021 - 10/15/2025 |
| Ticker: | Ticker: QNTM |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
Class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed. Quantum Biopharma intends to seek appointment as a lead plaintiff in this class action in order to assist in protecting its shareholders.